Senda Biosciences Announces Close of $123 Million Series C Financing by Jessica | Aug 16, 2022 Read more »
Orum Therapeutics Closes $84 Million Series B Financing To Advance Novel Targeted Protein Degrader Payloads Into Clinical Trials For Cancer by Jessica | Jun 24, 2022 Read more »
Halia Therapeutics Announces First Participant Dosed in Phase 1 Clinical Study of HT-6184, a Novel NEK7/NLRP3 Inhibitor by Jessica | Jun 15, 2022 Read more »
Alltrna Announces Formation of Scientific Advisory Board with World-Leading RNA Experts by Jessica | Mar 16, 2022 Read more »
Molecular Assemblies Announces $25.8 Million Series B Financing to Initiate Key Customer Program for Commercial Access to Fully Enzymatic DNA Synthesis by Jessica | Mar 15, 2022 Read more »
